[an error occurred while processing this directive] | [an error occurred while processing this directive]
Comparison of incidental irradiation dose to the internal mammary nodes among I-IMRT,F-IMRT,and 3DCRT after breast-conserving surgery
Song Yuanfang, Wang Wei, Li Jianbin, Sun Tao, Xu Min, Shao Qian
School of Medicine and Life Sciences,University of Jinan-Shandong Academy of Medical Sciences(Song YF); Department of Radiation Oncology(Song YF,Wang W,Li JB,Xu M,Shao Q),Department of Radiological Physics(Sun T),Shandong Cancer Hospital Affiliated to Shandong University,Jinan 250117,China
AbstractObjective To explore the dosimetric variance in incidental irradiation to the internal mammary nodes among inverse intensity-modulated radiotherapy (I-IMRT),forward intensity-modulated radiotherapy (F-IMRT),and three-dimensional conformal radiotherapy (3DCRT) after breast-conserving surgery,and to provide a basis for deciding whether to spare the internal mammary nodes in clinical treatment. Methods A total of 84 patients undergoing breast-conserving surgery were enrolled as subjects. The internal mammary nodes in the first three intercostal spaces were contoured. Three radiotherapy plans were designed for each patient. The internal mammary nodes were not included in the planning target volume. Comparison was made among the three plans. The Results were compared using Wilcoxon signed rank test. Results The I-IMRT,F-IMRT,and 3DCRT plans had similar median Dmean values for the internal mammary nodes,which were 2740.2,2973.9,and 2951.4 cGy,respectively. The analyses of the three individual intercostal spaces showed that there was no difference in Dmean for the first intercostal space or the second intercostal space between the three plans;For the third intercostal space,however,I-IMRT had a significantly higher Dmean than 3DCRT and F-IMRT. The analyses of the three individual plans showed that for each plan,the Dmean was the highest in the third intercostal space,followed by the second intercostal space and the first intercostal space. Conclusions All the three plans fail to attain an adequate prescribed dose to cure subclinical disease,and there is no significant difference among the three plans. Therefore,it is risky to exclude the internal mammary nodes using any one of the three radiotherapy techniques for patients with clinical indications for internal mammary nodes radiation. In the combination therapy including chemotherapy,endocrine therapy,and targeted therapy,however,further follow-up is needed to determine whether the incidental irradiation dose to the internal mammary nodes could meet clinical requirement.
Fund:The National Key Research Program of China (2016YFC0904700);Natural Science Foundation of Shandong Province (ZR2017PH006);National Natural Science Foundation of China (81703038);Key Research Development Program of Shandong Province (2017GSF18102)
Corresponding Authors:
Wang Wei,Email 18653478376@163.com;Li Jianbin,Email lijianbin@msn.com
Cite this article:
Song Yuanfang,Wang Wei,Li Jianbin et al. Comparison of incidental irradiation dose to the internal mammary nodes among I-IMRT,F-IMRT,and 3DCRT after breast-conserving surgery [J]. Chinese Journal of Radiation Oncology, 2018, 27(1): 63-67.
Song Yuanfang,Wang Wei,Li Jianbin et al. Comparison of incidental irradiation dose to the internal mammary nodes among I-IMRT,F-IMRT,and 3DCRT after breast-conserving surgery [J]. Chinese Journal of Radiation Oncology, 2018, 27(1): 63-67.
[1] Fisher B,Anderson S,Bryant J,et al. Twenty-year follow-up of a randomized trial comparing total mastectomy,lumpectomy,and lumpectomy plus irradiation for the treatment of invasive breast cancer[J].N Engl J Med,2002,347:1233-1241.DOI:10.1056/NEJMoa022152 [2] Whelan TJ,Olivotto IA,Parulekar WR,et al. Regional nodal irradiation in early-stage breast cancer[J].N Engl J Med,2015,373(4):307-316.DOI:10.1056/NEJMoa1415340 [3] Paszat LF,Mackillop WJ,Groome PA,et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer:A population-based study in Ontario,Canada[J].Int J Radiat Oncol Biol Phys,1999,43:755-762.DOI:10.1016/S0360-3016(98)00412-X [4] Hare GB,Proulx GM,Lamonica DM,et al. Internal mammary lymph node (IMN) coverage by standard radiation tangent fields in patients showing IMN drainage on lymphoscintigraphy:therapeutic implications[J].Am J Clin Oncol,2004,27(3):274-278.DOI:10.1097/01.coc.0000092596.03967.80 [5] Arora1 D,Frakes,J,Scott J,et al. Incidental radiation to uninvolved internal mammary lymph nodes in breast cancer[J].Breast Cancer Res Treat,2015,151:365-372.DOI:10.1007/s10549-015-3400-9 [6] Sapienza LG,Chen MJ,Gomes MJL,et al. Unintended irradiation of internal mammary chain-Is that enough?[J].Rep Pract Oncol Radiother,2016,21(1):25-30.DOI:10.1016/j.rpor.2015.07.006 [7] Kanyilmaz G,Aktan M,Koc M,et al. Unplanned irradiation of internal mammary lymph nodes in breast cancer[J].Radiol Med,2017,122(6):405-411.DOI:10.1007/s11547-017-0747-5 [8] Thorsen LBJ,Offersen BV,Danø H,et al. DBCG-IMN:a population-based cohort study on the effect of internal mammary node irradiation in early node-positive breast cancer[J].Clin Oncol,2016,34(4):314-320.DOI:10.1200/JCO.2015.63.6456 [9] Zhang FL,Wang YD,Xu WD,et al. Dosimetric evaluation of different intensity-modulated radiotherapy techniques for breast cancer after conservative surgery[J].Technol Cancer Res Treat,2015,14(5):515-523.DOI:10.1177/1533034614551873 [10] Noguchi M,Ohta N,Koyasaki N,et al. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer[J].Cancer,1991,68(9):1918-1925.DOI:10.1002/1097-0142(19911101)68:9<1918::AID-CNCR2820680913>3.0.CO;2-L [11] Offersen BV,Boersma LJ,Kirkove C,et al. ESTRO consensus guideline on target volume delineation for elective radiation therapy of early stage breast cancer,version 1.1[J].Radiother Oncol,2016,118(1):205-208.DOI:10.1016/j.radonc.2015.12.027 [12] Verhoeven K,Weltens C,Remouchamps V,et al. Vessel based delineation guidelines for the elective lymph node regions in breast cancer radiation therapy-PROCAB guidelines[J].Radiother Oncol,2016,118(1):209-210.DOI:10.1016/j.radonc.2015.12.005 [13] White JTA,Arthur D.Radiation therapy oncology group breast cancer contouring atlas.2016[2016-03-03].https://www.rtog.org/CoreLab/ContouringAtlases/BreastCancerAtlas.aspx [14] Withers HR,Peters LJ,Taylor JMG.Dose-response relationship for radiation therapy of subclinical disease[J].Int J Radiat Oncol Biol Phys,1995,31(2):353-359.DOI:10.1016/0360-3016(94)00354-N [15] Marks LB.A standard dose of radiation for “microscopic disease” is not appropriate[J].Cancer,1990,66(12):2498-2502.DOI:10.1002/1097-0142(19901215)66:12<2498::AID-CNCR2820661209>3.0.CO;2-X [16] Rosenzweig KE,Sim SE,Mychalczak B,et al. Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy[J].Int J Radiat Oncol Biol Phys,2001,50(3):681-685.DOI:10.1016/S0360-3016(01)01482-1 [17] Kataria T,Bisht SS,Gupta D,et al. Incidental radiation to axilla in early breast cancer treated with intensity modulated tangents and comparison with conventional and 3D conformal tangents[J].Breast,2013,22(6):1125-1129.DOI:10.1016/j.breast.2013.07.054 [18] Giuliano AE,Hunt KK,Ballman KV,et al. Axillary dissection vs. no axillary dissection in women with invasive breast cancer and sentinel node metastasis:a randomized clinical trial[J].JAMA,2011,305(6):569-575.DOI:10.1001/jama.2011.90 [19] Galper S,Recht A,Silver B,et al. Factors associated with regional nodal failure in patients with early stage breast cancer with 0-3 positive axillary nodes following tangential irradiation alone[J].Int J Radiat Oncol Biol Phys,1999,45(5):1157-1166.DOI:10.1016/S0360-3016(99)00334-X [20] Bouganim N,Tsvetkova E,Clemons M,et al. Evolution of sites of recurrence after early breast cancer over the last 20 years:implications for patient care and future research[J].Breast Cancer Res Treat,2013,139(2):603-606.DOI:10.1007/s10549-013-2561-7
2018, Vol. 27 
